The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-Bicyclo[2.2.1]hept-2-ylmethyl-1,3-dipropyl-3,7-dihydro-purine-2,6-dione ID: ALA2373406
Max Phase: Preclinical
Molecular Formula: C19H28N4O2
Molecular Weight: 344.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCn1c(=O)c2nc(C[C@H]3CC4CCC3C4)[nH]c2n(CCC)c1=O
Standard InChI: InChI=1S/C19H28N4O2/c1-3-7-22-17-16(18(24)23(8-4-2)19(22)25)20-15(21-17)11-14-10-12-5-6-13(14)9-12/h12-14H,3-11H2,1-2H3,(H,20,21)/t12?,13?,14-/m1/s1
Standard InChI Key: HQRJBFICGQWZHQ-JXQTWKCFSA-N
Molfile:
RDKit 2D
25 28 0 0 1 0 0 0 0 0999 V2000
5.0542 -3.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0542 -2.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -4.1667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6625 -2.9542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6625 -3.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -2.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8167 -4.0167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8167 -2.7167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2917 -3.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5292 -2.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1167 -3.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9667 -4.1667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5167 -2.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -1.7542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7750 -2.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6000 -0.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7292 -1.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -4.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9667 -2.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3625 -2.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3167 -2.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0542 -5.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2667 -2.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5750 -2.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0542 -6.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 5 1 0
5 3 1 0
6 2 1 0
7 1 1 0
8 2 1 0
9 7 1 0
10 11 1 1
11 9 1 0
12 5 2 0
10 13 1 0
14 6 2 0
15 10 1 0
16 13 1 0
17 15 1 0
18 3 1 0
19 4 1 0
20 13 1 0
21 17 1 0
22 18 1 0
23 19 1 0
24 23 1 0
25 22 1 0
8 9 2 0
6 4 1 0
17 16 1 0
21 20 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 344.46Molecular Weight (Monoisotopic): 344.2212AlogP: 2.69#Rotatable Bonds: 6Polar Surface Area: 72.68Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.69CX Basic pKa: 2.73CX LogP: 3.04CX LogD: 3.02Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.88Np Likeness Score: -0.51
References 1. Suzuki F, Shimada J, Mizumoto H, Karasawa A, Kubo K, Nonaka H, Ishii A, Kawakita T.. (1992) Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure., 35 (16): [PMID:1501234 ] [10.1021/jm00094a022 ] 2. Shimada J, Suzuki F, Nonaka H, Ishii A.. (1992) 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors., 35 (5): [PMID:1548682 ] [10.1021/jm00083a018 ]